Brief: 4D Molecular Therapeutics Says CFO Uneek Mehra To Resign
02/07/2025 21:21
July 2 (Reuters) - 4D Molecular Therapeutics Inc FDMT.O: 4D MOLECULAR THERAPEUTICS- ON JUNE 27, UNEEK MEHRA TO RESIGN AS CFO EFFECTIVE JULY 15- SEC FILING Further company coverage: FDMT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on 4D Molecular Therapeutics
See all news4D Molecular Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
4D Molecular Therapeutics Q2 net loss widens
Brief: 4D Molecular Therapeutics Q2 Net Income USD -72.936 Million Vs. IBES Estimate USD -70.3 Million
4D Molecular Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview
Brief: 4d Molecular Therapeutics Says 4D-150 Continues To Be Well Tolerated With No New Safety Findings